Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

West Nile virus back on UK public health agenda

This article was originally published in Clinica

Executive Summary

The UK's Health Protection Agency starts its annual West Nile virus (WNV) enhanced surveillance programme on June 1. In its fourth year, the scheme involves examining samples from adults with encephalitis or viral meningitis with no known cause, for the presence of the virus. "We continue to take the potential threat to the UK seriously," said the agency. In Europe, limited WNV transmission has been reported in recent years in south-east France, while last year two Irish tourists returning from Portugal's Algarve region were diagnosed. In the US, however, the mosquito-borne WNV is a major public health issue, with 9,858 cases reported in 2003, falling last year to 2,470.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT055297

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel